NDC product
GNP Calamine Topical Suspension
NDC 24385-413 · Amerisource Bergen
Key facts
| Product NDC | 24385-413 |
|---|---|
| Proprietary name | GNP Calamine Topical Suspension |
| Nonproprietary name | Calamine 8% and Zinc Oxide 8% |
| Substances | ZINC OXIDE |
| Dosage form | LOTION |
| Route | TOPICAL |
| Labeler | Amerisource Bergen |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M016 |
| Pharmacologic classes | Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE] |
| Marketing start | Jan 1, 2008 |
| Marketing end | Nov 1, 2029 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory